CPT code 64787 represents surgical implantation of a transected nerve end into bone or muscle performed after a separately reportable neuroma excision. The procedure addresses symptomatic neuromas and aims to prevent recurrent neuroma formation, reduce scar tissue development, and inhibit unwanted nerve regeneration. Nationally, this code is relevant to surgical specialties managing peripheral nerve injuries and chronic neuropathic pain, and it has implications for operative billing, post-operative care pathways, and payer coverage policies.

Key payers addressed in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find practical context on the clinical intent and typical setting for the service, plus a summary of what to expect from payer coverage frameworks and benchmarking materials. The publication provides a concise explanation of the code's clinical application, typical sites of service (hospital OR and ambulatory surgical center), and the common policy and billing considerations associated with neuroma-related surgical procedures. Where detailed payer-specific policies, associated taxonomies, ICD-10 diagnoses, or related codes are not present in the input, the report notes that those data are not available and focuses on the available clinical and billing description.